Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2025

The DurAVRTM Biomimetic TAVR System in Patients with Small Aortic Annuli (Anteris): One-Year Clinical and Hemodynamic Outcomes

Presenter: Rishi Puri

October 27, 2025

Presentation TVT 2023

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

Presenter: Eberhard Grube

June 08, 2023

Presentation TCT 2022

DurAVR THV First-in-Human Study - 30-day Results

Presenter: Christopher Meduri

September 18, 2022

Presentation TCT 2022

Leaflet Design's Impact on Physiology

Presenter: Joao Cavalcante

September 18, 2022

Presentation TCT 2022

Valve Function Insights from Bench Testing

Presenter: Janarthanan Sathananthan

September 18, 2022

Presentation TCT 2022

DurAVR THV Device Overview

Presenter: Christopher Meduri

September 18, 2022

TAVR of Yesterday is not the TAVR of the Future

Presentation TCT 2022

TAVR of Yesterday is not the TAVR fo the Future

Presenter: Nicolas Van Mieghem

September 18, 2022

Presentation TCT 2022

TAVR of Yesterday is not the TAVR fo the Future

Presenter: Nicolas Van Mieghem

September 18, 2022

Presentation TCT 2022

DurAVR™: Design Concept and FIH Results (Anteris)

Presenter: Vinayak N. Bapat

September 18, 2022

Presentation TVT 2021

A Novel Single Piece 3D TAVR With AntiCa+2 Treatment (Anteris)

Presenter: Paul Sorajja

July 22, 2021

Partner Content

Studying the Clinical Impact of Restoring Native Flow with Biomimetic DurAVR® THV

June 6, 2025

Partner Content

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

November 20, 2024

Partner Content

Studying the Clinical Impact of Restoring Native Flow

October 9, 2024

Partner Content

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

October 3, 2022

Video

» Topical Discussion

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

September 30, 2022

CME

Advertisement

The DurAVRTM Biomimetic TAVR System in Patients with Small Aortic Annuli (Anteris): One-Year Clinical and Hemodynamic Outcomes

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

DurAVR THV First-in-Human Study - 30-day Results

Leaflet Design's Impact on Physiology

Valve Function Insights from Bench Testing

DurAVR THV Device Overview

TAVR of Yesterday is not the TAVR fo the Future

TAVR of Yesterday is not the TAVR fo the Future

DurAVR™: Design Concept and FIH Results (Anteris)

A Novel Single Piece 3D TAVR With AntiCa+2 Treatment (Anteris)

Studying the Clinical Impact of Restoring Native Flow with Biomimetic DurAVR® THV

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

Studying the Clinical Impact of Restoring Native Flow

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content